Hybrid closed loop and intensive insulin delivery technology: Reviewing the effect of improving 'time in range' glucose levels on diabetic retinopathy.
作者信息
Varughese Maria S, Nayak Ananth U, Varadhan Lakshminarayanan
机构信息
University of Sheffield Medical School, Royal Hallamshire Hospital, Sheffield, South Yorkshire, UK.
University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, North Staffordshire, UK.
出版信息
Eye (Lond). 2025 Apr;39(6):1028-1030. doi: 10.1038/s41433-025-03730-4. Epub 2025 Feb 20.
Abstract
摘要
相似文献
1
Hybrid closed loop and intensive insulin delivery technology: Reviewing the effect of improving 'time in range' glucose levels on diabetic retinopathy.混合闭环与强化胰岛素输注技术：探讨改善血糖处于目标范围内的时间对糖尿病视网膜病变的影响
Eye (Lond). 2025 Apr;39(6):1028-1030. doi: 10.1038/s41433-025-03730-4. Epub 2025 Feb 20.
2
Glycaemic outcomes in adults with type 1 diabetes transitioning towards advanced automated insulin delivery systems - a real-world analysis at a Swiss tertiary centre.成人 1 型糖尿病患者向先进的自动胰岛素输送系统过渡的血糖结果-瑞士三级中心的真实世界分析。
Swiss Med Wkly. 2023 Dec 15;153:3501. doi: 10.57187/s.3501.
3
Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.妊娠期合并 1 型糖尿病患者的胰岛素自动化输注。
N Engl J Med. 2023 Oct 26;389(17):1566-1578. doi: 10.1056/NEJMoa2303911. Epub 2023 Oct 5.
4
Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review.美敦力 MiniMed 670G 在儿童、青少年和年轻成年人中的安全性、代谢和心理结局：系统评价。
Eur J Pediatr. 2023 May;182(5):1949-1963. doi: 10.1007/s00431-023-04833-4. Epub 2023 Feb 21.
5
Does fully closed-loop automated insulin delivery improve glycaemic control in patients with type 2 diabetes? A meta-analysis of randomized controlled trials.全闭环自动胰岛素给药能否改善2型糖尿病患者的血糖控制？一项随机对照试验的荟萃分析。
Diabet Med. 2024 Jan;41(1):e15196. doi: 10.1111/dme.15196. Epub 2023 Aug 18.
6
Effect of intensive glycemic control on the changes of diabetic retinopathy in type 2 diabetes: a prospective observational cohort study.强化血糖控制对2型糖尿病患者糖尿病视网膜病变变化的影响：一项前瞻性观察队列研究。
BMC Ophthalmol. 2025 May 26;25(1):313. doi: 10.1186/s12886-025-04139-z.
7
Performance of closed-loop systems for intravenous drug administration: a systematic review and meta-analysis of randomised controlled trials.静脉给药闭环系统的性能：随机对照试验的系统评价和荟萃分析。
J Clin Monit Comput. 2024 Feb;38(1):5-18. doi: 10.1007/s10877-023-01069-3. Epub 2023 Sep 11.
8
Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized Trial.在1型糖尿病儿童和青少年中使用剑桥混合算法的闭环自动胰岛素给药的成本效益：一项多中心6个月随机试验的结果
J Diabetes Sci Technol. 2024 Mar 17:19322968241231950. doi: 10.1177/19322968241231950.
9
Blood pressure control for diabetic retinopathy.糖尿病视网膜病变的血压控制。
Cochrane Database Syst Rev. 2023 Mar 28;3(3):CD006127. doi: 10.1002/14651858.CD006127.pub3.
10
Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.糖尿病胰岛素给药与血糖监测方法：一项比较有效性综述的总结
J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. doi: 10.18553/jmcp.2012.18.s6-A.1.
引用本文的文献
1
Hybrid closed loop devices: The utility of continuous glucose monitoring metrics for retinal surveillance during transition from standard insulin pump.混合闭环设备：从标准胰岛素泵转换期间连续血糖监测指标用于视网膜监测的效用
Eye (Lond). 2025 May 13. doi: 10.1038/s41433-025-03834-x.
本文引用的文献
1
The widening landscape of synthetic incretin treatment: possible association of ischaemic optic neuropathy risk and the need for a cautious approach.合成肠促胰岛素治疗的广阔前景：缺血性视神经病变风险的可能关联及谨慎对待的必要性。
Eye (Lond). 2025 Jun;39(8):1648-1649. doi: 10.1038/s41433-025-03776-4. Epub 2025 Apr 3.
2
Diabetic retinopathy and pregnancy: an overview of the predictive risk factors for progressive worsening of eye disease during the antenatal period.糖尿病视网膜病变与妊娠：孕期眼部疾病进行性恶化的预测风险因素概述
Eye (Lond). 2025 Apr;39(5):812-813. doi: 10.1038/s41433-025-03677-6. Epub 2025 Feb 14.
3
PCSK9 levels and diabetic retinopathy: opportunities for a potential target and novel therapeutic approach in conjunction with treating dyslipidaemia.前蛋白转化酶枯草溶菌素9水平与糖尿病视网膜病变：结合血脂异常治疗的潜在靶点及新治疗方法的机遇
Eye (Lond). 2025 Mar;39(4):628-630. doi: 10.1038/s41433-024-03523-1. Epub 2024 Dec 2.
4
PCSK9 Inhibitors and Lipid Lowering: Viewpoint on Diabetic Retinopathy.前蛋白转化酶枯草溶菌素9（PCSK9）抑制剂与降脂：关于糖尿病视网膜病变的观点
Ophthalmic Surg Lasers Imaging Retina. 2025 Jan;56(1):62-63. doi: 10.3928/23258160-20241101-05. Epub 2024 Nov 1.
5
Glycemic profile variability as an independent predictor of diabetic retinopathy in patients with type 2 diabetes: a prospective cohort study.血糖谱变异性作为 2 型糖尿病患者糖尿病视网膜病变的独立预测因子：一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2024 Nov 7;15:1383345. doi: 10.3389/fendo.2024.1383345. eCollection 2024.
6
Diabetic macular edema: Variations in observations with intensive treatment optimizing glycemia.糖尿病性黄斑水肿：强化治疗优化血糖水平时观察结果的差异
J Diabetes Complications. 2025 Jan;39(1):108909. doi: 10.1016/j.jdiacomp.2024.108909. Epub 2024 Nov 17.
7
SGLT2 inhibitors and diabetic retinopathy: Insights from the management of nephropathy.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病视网膜病变：来自肾病管理的见解
Eye (Lond). 2025 Feb;39(2):213-214. doi: 10.1038/s41433-024-03472-9. Epub 2024 Nov 12.
8
Fenofibrate therapy in reducing the progression of diabetic retinopathy: revisiting the FIELD and ACCORD-EYE studies through the LENS trial.非诺贝特治疗对糖尿病视网膜病变进展的影响：通过LENS试验重新审视FIELD和ACCORD-EYE研究
Eye (Lond). 2025 Jan;39(1):15-17. doi: 10.1038/s41433-024-03410-9. Epub 2024 Oct 22.
9
Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial.比较 1 型糖尿病孕妇的先进混合闭环治疗与标准胰岛素治疗（CRISTAL）：一项平行组、开放标签、随机对照试验。
Lancet Diabetes Endocrinol. 2024 Jun;12(6):390-403. doi: 10.1016/S2213-8587(24)00089-5. Epub 2024 Apr 30.
10
Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes.是否是时候超越 TIR 而采用 TITR 了？来自超过 20000 名 1 型和 2 型糖尿病患者使用连续血糖监测的真实世界数据。
Diabetes Technol Ther. 2024 Mar;26(3):203-210. doi: 10.1089/dia.2023.0565.
Zotero 插件